Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akashi-Tanaka

Showing results (91-100 of 122) with videos related to

Pageof 13
Sort By:
Japanese Journal of Clinical Oncology|February 26, 2008
Clinical efficacy of S-1 in pretreated metastatic breast cancer patientsTadahiko Shien, Chikako Shimizu, Sadako Akashi-Tanaka, et al.
Cancer Science|September 2, 2009
p53 expression in tumor stromal fibroblasts is associated with the outcome of patients with invasive ductal carcinoma of the breastTakahiro Hasebe, Nao Okada, Nobuko Tamura, et al.
Cancer Science|July 17, 2009
Tumor histology in lymph vessels and lymph nodes for the accurate prediction of outcome among breast cancer patients treated with neoadjuvant chemotherapyNobuko Tamura, Takahiro Hasebe, Nao Okada, et al.
Breast (Edinburgh, Scotland)|April 10, 2007
Favorable outcome in patients with breast cancer in the presence of pathological response after neoadjuvant endocrine therapySadako Akashi-Tanaka, Mutsuko Omatsu, Chikako Shimizu, et al.
Breast Cancer (Tokyo, Japan)|December 3, 2002
3D imaging of intraductal spread of breast cancer and its clinical application for navigation surgeryYasuhiro Tamaki, Sadako Akashi-Tanaka, Takanori Ishida, et al.
Cancer|January 19, 2012
Ipsilateral breast tumor recurrence (IBTR) in patients with operable breast cancer who undergo breast-conserving treatment after receiving neoadjuvant chemotherapy: risk factors of IBTR and validation of the MD Anderson Prognostic IndexMakoto Ishitobi, Shozo Ohsumi, Hideo Inaji, et al.
Human Pathology|February 15, 2011
Atypical tumor-stromal fibroblasts in invasive ductal carcinomas of the breast treated with neoadjuvant therapyTakahiro Hasebe, Motoki Iwasaki, Sadako Akashi-Tanaka, et al.
Breast Cancer Research and Treatment|February 21, 2008
Comparison among different classification systems regarding the pathological response of preoperative chemotherapy in relation to the long-term outcomeTadahiko Shien, Chikako Shimizu, Kunihiko Seki, et al.
Human Pathology|October 20, 2009
p53 expression in tumor-stromal fibroblasts is closely associated with the nodal metastasis and outcome of patients with invasive ductal carcinoma who received neoadjuvant therapyTakahiro Hasebe, Nobuko Tamura, Nao Okada, et al.
Breast Cancer (Tokyo, Japan)|June 29, 2022
Diagnostic performance of dedicated breast positron emission tomographyRikako Hashimoto, Sadako Akashi-Tanaka, Chie Watanabe, et al.
Pageof 13

Showing results (91-100 of 122) with videos related to

Sort By:
Pageof 13
Japanese Journal of Clinical Oncology|February 26, 2008
Clinical efficacy of S-1 in pretreated metastatic breast cancer patientsTadahiko Shien, Chikako Shimizu, Sadako Akashi-Tanaka, et al.
Cancer Science|September 2, 2009
p53 expression in tumor stromal fibroblasts is associated with the outcome of patients with invasive ductal carcinoma of the breastTakahiro Hasebe, Nao Okada, Nobuko Tamura, et al.
Cancer Science|July 17, 2009
Tumor histology in lymph vessels and lymph nodes for the accurate prediction of outcome among breast cancer patients treated with neoadjuvant chemotherapyNobuko Tamura, Takahiro Hasebe, Nao Okada, et al.
Breast (Edinburgh, Scotland)|April 10, 2007
Favorable outcome in patients with breast cancer in the presence of pathological response after neoadjuvant endocrine therapySadako Akashi-Tanaka, Mutsuko Omatsu, Chikako Shimizu, et al.
Breast Cancer (Tokyo, Japan)|December 3, 2002
3D imaging of intraductal spread of breast cancer and its clinical application for navigation surgeryYasuhiro Tamaki, Sadako Akashi-Tanaka, Takanori Ishida, et al.
Cancer|January 19, 2012
Ipsilateral breast tumor recurrence (IBTR) in patients with operable breast cancer who undergo breast-conserving treatment after receiving neoadjuvant chemotherapy: risk factors of IBTR and validation of the MD Anderson Prognostic IndexMakoto Ishitobi, Shozo Ohsumi, Hideo Inaji, et al.
Human Pathology|February 15, 2011
Atypical tumor-stromal fibroblasts in invasive ductal carcinomas of the breast treated with neoadjuvant therapyTakahiro Hasebe, Motoki Iwasaki, Sadako Akashi-Tanaka, et al.
Breast Cancer Research and Treatment|February 21, 2008
Comparison among different classification systems regarding the pathological response of preoperative chemotherapy in relation to the long-term outcomeTadahiko Shien, Chikako Shimizu, Kunihiko Seki, et al.
Human Pathology|October 20, 2009
p53 expression in tumor-stromal fibroblasts is closely associated with the nodal metastasis and outcome of patients with invasive ductal carcinoma who received neoadjuvant therapyTakahiro Hasebe, Nobuko Tamura, Nao Okada, et al.
Breast Cancer (Tokyo, Japan)|June 29, 2022
Diagnostic performance of dedicated breast positron emission tomographyRikako Hashimoto, Sadako Akashi-Tanaka, Chie Watanabe, et al.
Pageof 13